An optimised method for generation of murine CAR-T cells by CRISPR/Cas9.
Thomas John Jackson, Courtney Himsworth, Sophie Munnings-Tomes, Farah Alam, Helena Brezovjakova, Laura Donovan, Amy K. Erbe, Paul M. Sondel, Louis Chesler, John Anderson
This paper optimizes CRISPR/Cas9 AAV transduction for generating murine CAR-T cells with high efficiency and minimal toxicity, enabling in vivo persistence and pre-clinical testing.
bioRxiv · Nov 29, 2025 · PreprintMolecular Biology